{
    "Trade/Device Name(s)": [
        "HemoCue Hb 301 System"
    ],
    "Submitter Information": "HemoCue AB",
    "510(k) Number": "K201217",
    "Predicate Device Reference 510(k) Number(s)": [
        "K181751"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKR"
    ],
    "Summary Letter Date": "April 30, 2020",
    "Summary Letter Received Date": "May 6, 2020",
    "Submission Date": "April 30, 2020",
    "Regulation Number(s)": [
        "21 CFR 864.5620"
    ],
    "Regulation Name(s)": [
        "Automated hemoglobin system"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood",
        "Venous whole blood",
        "Arterial whole blood"
    ],
    "Specimen Container(s)": [
        "HemoCue Hb 301 Microcuvette"
    ],
    "Instrument(s)/Platform(s)": [
        "HemoCue Hb 301 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Spectrophotometric determination"
    ],
    "Methodologies": [
        "Direct spectrophotometric measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Microcuvette",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for HemoCue Hb 301 System, a spectrophotometric analyzer for quantitative hemoglobin measurement in whole blood using single-use microcuvettes.",
    "Indications for Use Summary": "Quantitative determination of hemoglobin in adults, adolescents, children, and infants above 1 month old in primary care and blood donation settings for professional in vitro diagnostic use.",
    "fda_folder": "Hematology"
}